Samsara BioCapital’s Liquidia Corp LQDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,013,773
Closed -$4.78M 34
2020
Q1
$4.78M Buy
1,013,773
+55,307
+6% +$274K 2.75% 9
2019
Q4
$4.1M Buy
958,466
+804,004
+521% +$3.23M 1.96% 13
2019
Q3
$550K Sell
154,462
-504,070
-77% -$2.98M 0.37% 18
2019
Q2
$5.27M Buy
658,532
+19,242
+3% +$181K 3.48% 9
2019
Q1
$7.28M Buy
639,290
+260,870
+69% +$4.18M 5.72% 8
2018
Q4
$8.2M Buy
+378,420
New +$8.85M 7.87% 6

Other funds holding LQDA

Samsara BioCapital's LQDA Position: Q2 2020 in Review

Samsara BioCapital sold out of Liquidia Corp (LQDA) in Q2 2020, closing a stake of 1,013,773 shares — an estimated $4.78M sold.

Samsara BioCapital first reported a position in LQDA in Q4 2018 and held it in 6 quarters. The position peaked at $8.2M in Q4 2018. 79 funds tracked by Wall St. Rank hold LQDA as of Q2 2020.

  • Samsara BioCapital reported no remaining Liquidia Corp position as of Q2 2020 after selling out during the quarter.
  • Samsara BioCapital sold 1,013,773 Liquidia Corp shares in Q2 2020, an estimated $4.78M.
  • Samsara BioCapital first reported a position in Liquidia Corp in Q4 2018 and held it in 6 quarters.
  • Samsara BioCapital's Liquidia Corp position peaked at $8.2M in Q4 2018.
  • 79 funds tracked by Wall St. Rank held Liquidia Corp as of Q2 2020.

Based on Samsara BioCapital's 13F filing for Q2 2020, filed 14 Aug 2020.